Default company panoramic image

Urinary BioSolutions, LLC

UBS will diagnose & treat urinary incontinence by uniquely locating the bladder neck & urethra in three dimensions and in real-time.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Baton Rouge, LA, USA
  • Currency USD
  • Founded March 2009
  • Employees 6

Company Summary

Urinary BioSolutions LLC (UBS) was formed in 2010 to improve healthcare diagnoses and outcomes for the tens millions of US patients with urinary incontinence by using a paradigm-shifting medical device. About 50 million American women experience some form of UI, ranging from mild to severe. Urinary incontinence in women costs the US healthcare system hundreds of billions of dollars and leads to a devastating impact on women’s quality of life.


  • Default avatar
    David Mishelevich, MD/PhD
    Chief Techonlogy Officer

    35 years experience developing information systems and medical devices including respiratory devices, remote manipulation of catheters, and Stereotactic Transcranial Magnetic Stimulation. VP and GM at IntelliCorp (knowledge systems); VP and GM at Circadian (disease management and medical devices) and of the AirWays Asthma Centers Division. CTO of several start-up companies. Has 20 patents issued and 48 pending and over 100 publications.

  • Default avatar
    Ramon Iglesias, MD
    Chief Medical Officer

    Dr. Iglesias is an obstetrics and gynecological physician with 30 years of experience treating SUI in his private practice in Miami, Florida. His passion of helping patients coupled with an entrepreneurial mindset prompted him to develop an effective diagnostic / treatment tool - a GPS for the human body - to diagnose and permanently solve SUI thereby improving the quality of life for his patients.

  • Default avatar
    Hank Mills
    Chief Executive Officer

    Mr. Mills has 25 years of experience in serial entrepreneurial ventures. His experience with private equity and marketing provides the neccesary expertise to raise needed capital and create strategic alliances for UBS to aggressively pursue product and commercial development. He has operationally guided UBS to its current stage by building a network of potential users and suppliers who work in concert to help launch the UPD.

  • Default avatar
    Yolanda Lorié
    Chief Operating Officer

    Ms. Lorie is 20 years of experience in marketing and business administration for various private ventures including one of the biggest bilingual publications in Latin America including several bilingual medical publications. Her experience in print media will be critical in building the grassroots awareness campaign among UI sufferers as well as the medical service providers.


  • Default avatar
    Dewey & LeBoeuf (IP law firm); Fabian & Clendenin (corporate attorney)

Previous Investors

  • Default avatar